Adial Pharmaceuticals (ADIL)

• Market cap: $5.69M
• 1 day: -5.45%
• 5 days: 2.77%
• 1 month: 61.49%
• 3 months: 52.94%
• 6 months: -60.31%
• Year to date: -56.52%
• 1 year: -56.52%
• 5 years: -99.86%
• 10 years: -99.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Employees: 6